Shanghai Ninth Peoples Hospital

Shanghai 200025

2 studies enrolling now · 6 studies all time

What they study most

Acute Coronary Syndrome, Atrial Fibrillation, Blood Pressure, Crohn's Disease, Squamous Cell Carcinoma of the Head and Neck

Studies at this site

• The GUARDIAN Trial — Recruiting now
• A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
• A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX) — Stopped early
• The GUARDIAN Trial - Vasopressor Sub-Study — Enrolling by invitation